GTC Biotherapeutics, Inc. (Nasdaq: GTCB) has received a $1 million milestone payment from OVATION Pharmaceuticals, Inc., the commercialization and development ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE